Quabodepistat

DB17770InvestigationalSmall molecule

Quabodepistat: Overview.

Chemical structure of Quabodepistat
Formula / weight
C21H20ClF3N2O4 · 456.85 g/mol (avg)
Also known as
2(1H)-QUINOLINONE, 5-(((3R,4R)-1-(4-CHLORO-2,6-DIFLUOROPHENYL)-3,4-DIHYDROXY-4-PIPERIDINYL)METHOXY)-8-FLUORO-3,4-DIHYDRO- · 5-(((3r,4r)-1-(4-chloro-2,6-difluorophenyl)-3,4-dihydroxypiperidin-4-yl)methoxy)-8-fluoro-3,4-dihydroquinolin-2(1h)-one · 5-{[(3R,4R)-1-(4-chloro-2,6-difluorophenyl)-3,4-dihydroxypiperidin-4-yl]methoxy}-8-fluoro-3,4-dihydroquinolin-2(1H)-one
Code names
OPC-167832

Resolves to

Compound
UNII1PQN78P4S3CAS1883747-71-4
Structure
InChIKeyXZISSTDXPBUCJA-DYESRHJHSA-NSMILESO[C@@H]1CN(CC[C@@]1(O)COC1=CC=C(F)C2=C1CCC(=O)N2)C1=C(F)C=C(Cl)C=C1F

What you can answer from here — as of January 07, 2026

8Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Quabodepistat, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In